An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 μg for first-trimester legal medical abortion

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 11, 2005, Pages 1098-

  Ravn, Pernille ^a   Rasmussen, Åse ^a   Knudsen, Ulla Breth ^a   Kristiansen, Frank Vous ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Fredericia Sygehus   (Denmark)

Author keywords

First trimester; Medical abortion; Oral mifepristone; Oral misoprostol; Outpatient

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; DIARRHEA; DISEASE SEVERITY; ENDOMETRIUM; EVALUATION; FEMALE; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; NAUSEA; OUTPATIENT; PAIN ASSESSMENT; PELVIC INFLAMMATORY DISEASE; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UTERUS; VACUUM ASPIRATION; VAGINA BLEEDING; VOMITING;

EID: 27644535857     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00868.x     Document Type: Article

References (21)

1. Kovacs L, Sas M, Resch BA, Ugocsai G, Swahn ML, Bygdeman M et al. Termination of very early pregnancy by RU 486 - an antiprogestational compound. Contraception 1984; 29: 399-410.
2. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-87.
3. Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509-13.
4. Honkanen H, Piaggio G, Hertzen H, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K et al. for the WHO Research Group on Post-Ovulatory Methods for Fertility Regulation. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG 2004; 111: 715-25.
5. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991; 338: 233-36.
6. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992; 99: 1004-7.
7. Knudsen UB. First trimester abortion with mifepristone and vaginal misoprostol. Contraception 2001; 63: 247-50.
8. Bygdeman M, Danielsson KG. Options for early therapeutic abortion: a comparative review. Drugs 2002; 62: 2459-70.
9. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med 1998; 7: 360-66.
10. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004: (1): CD002855.
11. Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Sivestre L et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Menopausal Stud 1995; 40(Suppl. 2): 85-91.
12. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997; 44: 353-60.
13. Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol 2000; 183: S44-53.
14. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88-92.
15. Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 2004; 103(Pt 1): 866-70.
16. Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999; 93: 275-80.
17. Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 2003; 18: 2315-18.
18. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993; 8: 1502-5.
19. el-Rafaey H, Templeton A. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure. Br J Obstet Gynaecol 1994; 101: 792-96.
20. Aubeny E, Chatellier G. A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 2000; 5: 171-76.
21. Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104: 829-33.